GT Biopharma, Inc. Modification Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Convertible Note between GT Biopharma, Inc. and Alto Opportunity Master Fund, SPC
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2021
Amendment to Convertible Note between GT Biopharma, Inc. and Holder (Effective January 2021)
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2021
Amendment Agreement to Preferred Stock Exchange Agreements between GT Biopharma Inc. and Preferred Stockholders
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2017
Amendment Agreement to Warrant Exercise Agreements between GT Biopharma Inc. and Warrant Holders
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2017
Amendment Agreement to Note Conversion Agreements between GT Biopharma Inc. and Note Holders (October 2017)
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2017
Amendment to Note Conversion Agreement between OXIS International, Inc. and Investors
Modification Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016